GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio View Ltd (XTAE:BIOV) » Definitions » Price-to-Owner-Earnings

Bio View (XTAE:BIOV) Price-to-Owner-Earnings : (As of May. 29, 2025)


View and export this data going back to 2006. Start your Free Trial

What is Bio View Price-to-Owner-Earnings?

As of today (2025-05-29), Bio View's share price is ₪0.247. Bio View does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Bio View's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Bio View was 128.60. The lowest was 8.20. And the median was 18.19.


XTAE:BIOV's Price-to-Owner-Earnings is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 27.88
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-29), Bio View's share price is ₪0.247. Bio View's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₪-0.03. Therefore, Bio View's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-29), Bio View's share price is ₪0.247. Bio View's EPS without NRI for the trailing twelve months (TTM) ended in was ₪-0.03. Therefore, Bio View's PE Ratio without NRI for today is At Loss.

During the past 13 years, Bio View's highest PE Ratio without NRI was 119.00. The lowest was 0.00. And the median was 23.54.


Bio View Price-to-Owner-Earnings Historical Data

The historical data trend for Bio View's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio View Price-to-Owner-Earnings Chart

Bio View Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 80.20 14.86 123.23 - -

Bio View Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 123.23 180.00 - - -

Competitive Comparison of Bio View's Price-to-Owner-Earnings

For the Medical Devices subindustry, Bio View's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio View's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio View's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Bio View's Price-to-Owner-Earnings falls into.


;
;

Bio View Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Bio View's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.247/-0.03
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio View  (XTAE:BIOV) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Bio View Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Bio View's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio View Business Description

Traded in Other Exchanges
N/A
Address
3 Pekeris Street, Rehovot, ISR, 7670203
Bio View Ltd is an Israel based company engaged in the research, development, manufacture, marketing, and sale of computerized systems for identification of rate cells and test for detection of cancer. It manufactures and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, pathology clinical and research laboratories. Geographically, the group has its business presence in Israel, USA, and other countries, of which majority of the revenue is derived from the USA.

Bio View Headlines

No Headlines